Cargando…

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease

Dynamic causal modeling (DCM) is a framework for making inferences about changes in brain connectivity using neuroimaging data. We fitted DCMs to high-density EEG data from subjects performing a semantic picture matching task. The subjects are carriers of the PSEN1 mutation, which leads to early ons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penny, Will, Iglesias-Fuster, Jorge, Quiroz, Yakeel T., Lopera, Francisco Javier, Bobes, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923812/ https://www.ncbi.nlm.nih.gov/pubmed/29562504 http://dx.doi.org/10.3233/JAD-170405

Ejemplares similares

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
por: Guzmán-Vélez, Edmarie, et al.
Publicado: (2022)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
por: Norton, Daniel J., et al.
Publicado: (2020)

Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease
por: Vannini, Patrizia, et al.
Publicado: (2020)

The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
por: Vila-Castelar, Clara, et al.
Publicado: (2020)

White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia
por: Schoemaker, Dorothee, et al.
Publicado: (2022)

Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer’s disease
por: Pardilla-Delgado, Enmanuelle, et al.
Publicado: (2021)

Spectral Analysis of EEG in Familial Alzheimer's Disease with E280A Presenilin-1 Mutation Gene
por: Rodriguez, Rene, et al.
Publicado: (2014)

Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease
por: Langella, Stephanie, et al.
Publicado: (2023)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort
por: Fox-Fuller, Joshua T., et al.
Publicado: (2021)

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
por: Müller, Stephan, et al.
Publicado: (2017)

Memory for Semantically Related Objects Differentiates Cognitively Unimpaired Autosomal Dominant Mutation Carriers from Non-Carrier Family Members
por: Fox-Fuller, J. T., et al.
Publicado: (2023)

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man
por: Lopera, Francisco, et al.
Publicado: (2023)

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
por: Sepulveda-Falla, Diego, et al.
Publicado: (2022)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report
por: Arboleda-Velasquez, Joseph F., et al.
Publicado: (2019)

Cortical thickness across the lifespan in a Colombian cohort with autosomal‐dominant Alzheimer's disease: A cross‐sectional study
por: Fox‐Fuller, Joshua T., et al.
Publicado: (2021)

Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
por: Sanchez, Justin S., et al.
Publicado: (2021)

Zebrafish Models of Autosomal Dominant Ataxias
por: Quelle-Regaldie, Ana, et al.
Publicado: (2021)

The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
por: Tariot, Pierre N., et al.
Publicado: (2018)

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
por: Schindler, Suzanne Elizabeth, et al.
Publicado: (2015)

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
por: Chen, Kewei, et al.
Publicado: (2012)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
por: Johansson, Charlotte, et al.
Publicado: (2023)

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
por: Bateman, Randall J, et al.
Publicado: (2011)

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease
por: Vilaplana, Eduard, et al.
Publicado: (2020)

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
por: Raman, Rema, et al.
Publicado: (2021)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Abnormal retinal capillary blood flow in autosomal dominant Alzheimer's disease
por: Singer, Maxwell B., et al.
Publicado: (2021)

Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer’s disease
por: Levitis, Elizabeth, et al.
Publicado: (2022)

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease
por: Tu, Jiaxin Cindy, et al.
Publicado: (2023)

A Spanish Neuropsychological Battery Discriminates Between the Behavioral Variant of Frontotemporal Dementia and Primary Progressive Aphasia in a Colombian Sample
por: Velilla, Lina, et al.
Publicado: (2021)

Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
por: Brase, Logan, et al.
Publicado: (2023)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
por: Pera, Marta, et al.
Publicado: (2012)

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2016)

Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease
por: Muenchhoff, Julia, et al.
Publicado: (2016)

Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis
por: Pavisic, Ivanna M., et al.
Publicado: (2020)

Acculturation moderates cognitive performance in adults at risk of autosomal dominant Alzheimer's Disease.
por: Tureson, Kayla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2n5t70jdo38662nr2p3525u3fe